MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
MetLife, Inc.NYSE: MET
Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Financing cash flow grows, but more slowly than its trailing trend
Q2 FY2026 financing cash flow of $3.22B rose 121.9% year over year, behind the +131625.0% change in trailing-twelve-month financing cash flow. Sequentially, it fell 9.6% from the prior quarter.
Context
- Financing cash flow amounted to 0.2% of revenue in FY2025, down 4.3 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +121.9% toward the trailing-twelve-month pace of +131625.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 163M USD
- Year-over-year change
- +105.2%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 163M | +105.2% |
| FY2024 | 2024-12-31 | (3.13B) | -6.5% |
| FY2023 | 2023-12-31 | (2.94B) | +70.4% |
| FY2022 | 2022-12-31 | (9.95B) | -623.5% |
| FY2021 | 2021-12-31 | (1.38B) | — |
Financing Cash Flow vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +131625.0% is the highest of 11, against a peer median of +27.9%.
- Financing cash flow amounts to 6.7% of revenue for MET, versus a peer median of 22.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $19.76B USD | -8.1% | +61.5% | 30.5% | |
| LTM Jun 2026 | $6.92B USD | +55.1% | -3.5% | 35.8% | |
| LTM Jun 2026 | $5.27B USD | +131625.0% | — | 6.7% | |
| LTM Jun 2026 | $4.85B USD | +45.5% | +4.6% | 26.8% | |
| LTM Sep 2026 | $4.84B USD | +664.1% | — | 89.2% | |
| LTM Jun 2026 | $1.59B USD | +1501.8% | — | 34.1% | |
| LTM Jun 2026 | $997.5M USD | -29.0% | +43.7% | 7.5% | |
| LTM Jun 2026 | CA$896.15M CAD | -85.2% | -1.0% | 1.5% | |
| LTM Jun 2026 | $710M USD | +64.4% | — | 18.8% | |
| LTM Jun 2026 | $627.1M USD | +10.3% | +9.4% | 18.4% | |
| LTM Jun 2026 | $490.52M USD | -48.4% | +16.0% | 7.9% | |
| Peer median (excluding MET) | — | +27.9% | +9.4% | 22.8% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 6.55B | 5.28B | 1.58B | 4.43B | 3.38B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 2.64B | 1.9B | 2.18B | 1.85B | 6.84B |
| Accounts Receivables | 362M | 299M | 0 | 460M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 2.27B | 1.6B | 2.18B | 1.39B | 6.84B |
| Other Non-Cash Items | 2.94B | 3.52B | 9.78B | 8.13B | 7.14B |
| Operating Cash Flow | 12.83B | 11.37B | 14.26B | 15.12B | 18.11B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 3.27B | (709M) | (755M) | (358M) | (738M) |
| Purchases of Investments | (109.32B) | (104.64B) | (84.27B) | (82.14B) | (105.7B) |
| Sales of Investments | 110.79B | 108.43B | 76.1B | 69.94B | 92.87B |
| Other Investing Activities | (20.29B) | (5.7B) | (143M) | 1.07B | (2.04B) |
| Investing Cash Flow | (11.19B) | (2.62B) | (10.25B) | (11.49B) | (15.61B) |
| Debt Repayment | (632M) | 878M | 875M | (982M) | (566M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (4.8B) | (3.33B) | (3.1B) | (3.21B) | (3.88B) |
| Dividends Paid | (1.84B) | (1.78B) | (1.76B) | (1.73B) | (1.7B) |
| Other Financing Activities | 5.9B | (5.72B) | 1.05B | 2.79B | 6.32B |
| Financing Cash Flow | (1.38B) | (9.95B) | (2.94B) | (3.13B) | 163M |
| Effect of Forex Changes | (13M) | 1.34B | (630M) | (1.06B) | (697M) |
| Net Change in Cash | 252M | 148M | 444M | (571M) | 1.96B |
| Free Cash Flow | 12.83B | 11.37B | 14.26B | 15.12B | 18.11B |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.